Psychometric properties of the Anxiety Inventory for Respiratory Disease in patients with COPD in China

Abstract

BackgroundAnxiety is a common comorbidity in patients with COPD in China, and it can significantly decrease patients’ quality of life. Almost all anxiety measurements contain somatic items that can overlap with symptoms of COPD and side effects of medicines, which can lead to bias in measuring anxiety in patients with COPD. Therefore, a brief and disease-specific non-somatic anxiety measurement scale, the Anxiety Inventory for Respiratory Disease (AIR), which has been developed and validated in its English version, is needed for patients with COPD in China.MethodsA two-center study was conducted in two tertiary hospitals in Tianjin, China. A total of 181 outpatients with COPD (mean age 67.21±8.10 years, 32.6% women), who met the inclusion and exclusion criteria, were enrolled in the study. Test–retest reliability was examined using intraclass correlation coefficients. The internal consistency was calculated by Cronbach’s α. Content validity was examined using the Content Validity Index (CVI), scale-level CVI/universal agreement, and scale-level CVI/average agreement (S-CVI/Ave). Besides, convergent validity and construct validity were also examined.ResultsThe AIR-C (AIR-Chinese version) scale had high test–retest reliability (intraclass correlation coefficient =0.904) and internal consistency (Cronbach’s α=0.914); the content validity of the AIR-C scale was calculated by CVI, scale-level CVI/universal agreement, and S-CVI/Ave at values of 0.89–1, 0.90, and 0.98, respectively. Meanwhile, the AIR-C scale had good convergent validity, correlating with the Hospital Anxiety and Depression Scale-Anxiety (r=0.81, P<0.01), and there were significant correlations between the AIR-C and Clinical COPD Questionnaire (CCQ; r=0.44, P<0.01) and Activities of Daily Living Scale (ADLS; r=0.36, P<0.01). A two-factor model of general anxiety and panic symptoms in the AIR-C scale had the best fit according to Confirmatory Factor Analysis (CFA).ConclusionThe AIR-C scale had a good reliability and validity for patients with COPD and can be used as a user-friendly and valid tool for measuring anxiety symptoms among patients with COPD in China.

Pharmacological Investigation of the Anti-Inflammation and Anti-Oxidation Activities of Diallyl Disulfide in a Rat Emphysema Model Induced by Cigarette Smoke Extract

“…Chronic obstructive pulmonary disease (COPD), as a major worldwide health problem, is characterized by persistent airflow limitation which is usually progressive and associated with an enhanced chronic inflammatory response in the airway and the lung to noxious particles or gases [ 1 , 2 ]. The World Health Organization (WHO) has estimated that it will increase to being the third leading cause of death, making this a global epidemic by 2020 [ 3 ].…”

Does pulmonary rehabilitation alleviate depression in older patients with chronic obstructive pulmonary disease

“…Depression is a common comorbidity in patients with COPD 16. Studies report that depression may cause worsening of the quality of life, social isolation, physical impairment, prolonged hospitalization, and increased risk of mortality 17,18. Recent reviews have reported that 25% of COPD patients have some degree of depression 19.…”

Evaluation of the effects of Covid 19 on the mental health of staff in a private hospital for coronary patients

“…Therefore, although the usual community structures are disrupted by behaviors or dexterity, stronger community structures and more positive functioning can emerge in the community [32]. Practice disease prevention Corona, the new target is the social life of the people affected, and makes people feel that compliance with them can be not only the health of the body, which They should also dominate the health of the society and see themselves as the rulers of the conditions and not the victims.…”